Early postoperative growth in non-functioning pituitary adenomas; A tool to tailor safe follow-up
Non-functioning pituitary adenomas are common, and the treatment and follow-up of these patients represent a multidisciplinary challenge. First line treatment is transphenoidal surgery, with debulking or total removal of tumour. A substantial portion of the tumours relapse after surgery, and there is no consensus of how to follow these patients postoperatively. Our aim was to characterize the postoperative growth of non-functioning pituitary adenomas and correlate it to clinical and paraclinical data.
We retrospectively registered 52 patients operated for non-functioning pituitary adenomas, with four or more consecutive MR-investigations not interrupted by secondary treatment. Adenoma volumes were estimated by the Cavalieri principle with summation of manually drawn areas multiplied by slice interval. Growth curves were modelled and tumour volume doubling time was calculated for 39 tumours with regrowth after surgery.
A total of 13 tumours showed exponential growth, 10 linear growth and 16 logistic growth after surgery. The remaining 13 did not show regrowth of tumour. Seven of the exponential growing tumours underwent secondary surgery, compared to one and two of linear and logistic growing tumours (p = 0.03), respectively. Initial tumour volume doubling time was significantly lower in logistic growing tumours than in exponential growing tumours (p < 0.01). Men had tumours with lower tumour volume doubling time than women (p = 0.03). None of the tumours demonstrated signs of accelerated growth.
Residual tumours following surgery frequently grow. The logistic growing tumours had the fastest initial growth in our cohort. We found no indication of accelerated growth, whereby the tumour volume doubling time might be used to predict a “worst-case” scenario when planning follow-up of these patients.
KeywordsAnterior pituitary Tumour volume doubling time Non-functioning pituitary adenoma Growth dynamics prognosis
K.A.Ø. and J.B. designed the research studies. K.A.Ø. and G.A.R. performed the volume registrations. O.C.B. performed the immunohistochemical investigations. M.Z. performed the growth model fitting. K.A.Ø. and M.Z. analyzed the data. K.A.Ø., M.Z., O.C.B., G.A.R. and J.B. wrote the manuscript.
Compliance with ethical standards
Conflict of interest
Jens Bollerslev is a member of the advisory board of JCEM and Endocrine. The remaining authors declare that they have no competing interests.
The study was approved by the regional ethics committee and hospital authority
The informed consentwas obtained from all living patients.
- 2.T.T. Agustsson, T. Baldvinsdottir, J.G. Jonasson, E. Olafsdottir, V. Steinthorsdottir, G. Sigurdsson, A.V. Thorsson, P.V. Carroll, M. Korbonits, R. Benediktsson, The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study. Eur. J. Endocrinol. 173(5), 655–664 (2015). doi:10.1530/eje-15-0189 CrossRefPubMedGoogle Scholar
- 6.S. Brochier, F. Galland, M. Kujas, F. Parker, S. Gaillard, C. Raftopoulos, J. Young, O. Alexopoulou, D. Maiter, P. Chanson, Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients. Eur. J. Endocrinol. 163(2), 193–200 (2010). doi:10.1530/eje-10-0255 CrossRefPubMedGoogle Scholar
- 7.E.P. O’Sullivan, C. Woods, N. Glynn, L.A. Behan, R. Crowley, P. O’Kelly, D. Smith, C.J. Thompson, A. Agha, The natural history of surgically treated but radiotherapy-naive nonfunctioning pituitary adenomas. Clin. Endocrinol. 71(5), 709–714 (2009). doi:10.1111/j.1365-2265.2009.03583.x CrossRefGoogle Scholar
- 8.M. Losa, P. Mortini, R. Barzaghi, P. Ribotto, M.R. Terreni, S.B. Marzoli, S. Pieralli, M. Giovanelli, Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence. J. Neurosurg. 108(3), 525–532 (2008). doi:10.3171/jns/2008/108/3/0525 CrossRefPubMedGoogle Scholar
- 22.Y. Tanaka, K. Hongo, T. Tada, K. Sakai, Y. Kakizawa, S. Kobayashi, Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index. J. Neurosurg. 98(2), 359–365 (2003). doi:10.3171/jns.2003.98.2.0359 CrossRefPubMedGoogle Scholar
- 23.J.A. Balogun, E. Monsalves, K. Juraschka, K. Parvez, W. Kucharczyk, O. Mete, F. Gentili, G. Zadeh, Null cell adenomas of the pituitary gland: an institutional review of their clinical imaging and behavioral characteristics. Endocr. Pathol. 26(1), 63–70 (2015). doi:10.1007/s12022-014-9347-2 CrossRefPubMedGoogle Scholar
- 25.E. Monsalves, S. Larjani, B. Loyola Godoy, K. Juraschka, F. Carvalho, W. Kucharczyk, A. Kulkarni, O. Mete, F. Gentili, S. Ezzat, G. Zadeh, Growth patterns of pituitary adenomas and histopathological correlates. J. Clin. Endocrinol. Metab. 99(4), 1330–1338 (2014). doi:10.1210/jc.2013-3054 CrossRefPubMedGoogle Scholar
- 26.H.J. Gundersen, T.F. Bendtsen, L. Korbo, N. Marcussen, A. Moller, K. Nielsen, J.R. Nyengaard, B. Pakkenberg, F.B. Sorensen, A. Vesterby et al.. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96(5), 379–394 (1988)CrossRefPubMedGoogle Scholar
- 28.J.K. Varughese, T. Wentzel-Larsen, F. Vassbotn, G. Moen, M. Lund-Johansen, Analysis of vestibular schwannoma size in multiple dimensions: a comparative cohort study of different measurement techniques. Clin. Otolaryngol. 35(2), 97–103 (2010). doi:10.1111/j.1749-4486.2010.02099.x CrossRefPubMedGoogle Scholar
- 29.N. Lenders, S. Ikeuchi, A.W. Russell, K.K. Ho, J.B. Prins, W.J. Inder Longitudinal evaluation of the natural history of conservatively managed non-functioning pituitary adenomas. Clin. Endocrinol.. (2015). 10.1111/cen.12879
- 30.A. Colao, M.D. Bronstein, P. Freda, F. Gu, C.C. Shen, M. Gadelha, M. Fleseriu, A.J. van der Lely, A.J. Farrall, K. Hermosillo Resendiz, M. Ruffin, Y. Chen, M. Sheppard, Pasireotide versus octreotide in acromegaly: a head-to-head superiority study. J. Clin. Endocrinol. Metab. 99(3), 791–799 (2014). doi:10.1210/jc.2013-2480 CrossRefPubMedPubMedCentralGoogle Scholar
- 33.M.A. Mooney, D.A. Hardesty, J.P. Sheehy, R. Bird, K. Chapple, W.L. White, A.S. Little Interrater and intrarater reliability of the Knosp scale for pituitary adenoma grading. J. Neurosurg. 1–6 (2016). 10.3171/2016.3.jns153044
- 35.O. Casar-Borota, K.A. Oystese, M. Sundstrom, L. Melchior, V. Popovic A high-throughput analysis of the IDH1(R132H) protein expression in pituitary adenomas. Pituitary. (2016). 10.1007/s11102-016-0720-7
- 36.M. Stone, An asymptotic equivalence of choice of model by cross-validation and Akaike’s criterion. J. R. Stat. Soc. Series B Methodol. 39(1), 44–47 (1977)Google Scholar
- 38.E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, L. Rubinstein, L. Shankar, L. Dodd, R. Kaplan, D. Lacombe, J. Verweij, New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer. 45(2), 228–247 (2009). doi:10.1016/j.ejca.2008.10.026 CrossRefPubMedGoogle Scholar
- 40.H. Nishioka, N. Inoshita, O. Mete, S.L. Asa, K. Hayashi, A. Takeshita, N. Fukuhara, M. Yamaguchi-Okada, Y. Takeuchi, S. Yamada The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas. Endocr. Pathol. (2015). doi:10.1007/s12022-015-9398-z
- 42.D.S. Olsson, A.G. Nilsson, I.L. Bryngelsson, P. Trimpou, G. Johannsson, E. Andersson, Excess Mortality in Women and Young Adults With Nonfunctioning Pituitary Adenoma: A Swedish Nationwide Study. J. Clin. Endocrinol. Metab. 100(7), 2651–2658 (2015). doi:10.1210/jc.2015-1475 CrossRefPubMedGoogle Scholar